Endothelial dysfunction in chronic obstructive pulmonary disease

Angiology

Volumn 59, Issue 3, 2008, Pages 357-364

  Moro, Leo ^a   Pedone, Claudio ^a   Scarlata, Simone ^a   Malafarina, Vincenzo ^a   Fimognari, Filippo ^b   Antonelli Incalzi, Raffaele ^a  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^b Leopoldo Parodi Delfino Hospital   (Italy)

Author keywords

Atherosclerosis; COPD; Endothelial dysfunction

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLYCERYL TRINITRATE; NITRATE;

AGED; ARTICLE; ATHEROSCLEROSIS; BODY MASS; BRONCHUS OBSTRUCTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENDOTHELIAL DYSFUNCTION; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION TEST; MALE; SPIROMETRY; VASODILATATION;

ADMINISTRATION, ORAL; AGED; BRACHIAL ARTERY; BRONCHOCONSTRICTION; CAROTID ARTERY, COMMON; ENDOTHELIUM, VASCULAR; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; HYPEREMIA; MALE; NITROGLYCERIN; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REGIONAL BLOOD FLOW; SPIROMETRY; VASODILATION; VASODILATOR AGENTS; VITAL CAPACITY;

EID: 44849108219     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/0003319707306141     Document Type: Article

References (38)

1. Murray CJ, Lopez AD Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet. 1997 ; 349: 1498-1504.
2. Antonelli Incalzi R., Fuso L., De Rosa M., et al. Co-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease. Eur Respir J. 1997 ; 10: 2794-2800.
3. Sin DD, Man SF Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation. 2003 ; 107: 1514-1519.
4. Fuso L., Incalzi RA, Pistelli R., et al. Predicting mortality of patients hospitalized for acutely exacerbated chronic obstructive pulmonary disease. Am J Med. 1995 ; 98: 272-277.
5. Ferrer M., Alonso J., Morera J., et al. Chronic obstructive pulmonary disease stage and health-related quality of life. The Quality of Life of Chronic Obstructive Pulmonary Disease Study Group. Ann Intern Med. 1997 ; 127: 1072-1079.
6. Hole DJ, Watt GC, Davey-Smith G., Hart CL, Gillis CR, Hawthorne VM Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study. BMJ. 1996 ; 313: 711-715.
7. van Eeden SF, Yeung A., Quinlam K., Hogg JC Systemic response to ambient particulate matter: relevance to chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2005 ; 2: 61-67.
8. Incalzi RA, Bellia V., Catalano F., Scichilone N., Imperiale C., Maggi S., Rengo F. Evaluation of health outcomes in elderly patients with asthma and COPD using disease-specific and generic instruments: the Salute Respiratoria nell'Anziano (Sa.R.A.) Study. Chest. 2001 ; 120: 734-742.
9. Kim JA, Montagnani M., Koh KK, Quon MJ Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation. 2006 ; 113: 1888-1904.
10. Gan WQ, Man SF, Senthilselvan A., Sin DD Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax. 2004 ; 59: 574-580.
11. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999 ; 340: 115-126.
12. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med. 2005 ; 171: 912-930.
13. Ward ME Dilation of rat diaphragmatic arterioles by flow and hypoxia: roles of nitric oxide and prostaglandins. J Appl Physiol. 1999 ; 86: 1644-1650.
14. Bellia V., Battaglia S., Catalano F., et al. Aging and disability affect misdiagnosis of COPD in elderly asthmatics: the SARA study. Chest. 2003 ; 123: 1066-1072.
15. Davignon J., Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation. 2004 ;109: 11127-11132.
16. Behrendt D., Ganz P. Endothelial function. From vascular biology to clinical applications. Am J Cardiol. 2002 ; 90: 40L - 48L.
17. Raitakari OT, Celermajer DS Flow-mediated dilatation. Br J Clin Pharmacol. 2000 ; 50: 397-404.
18. Corretti MC, Anderson TJ, Benjamin EJ, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol. 2002 ; 39: 257-265.
19. O'Leary DH, Polak JF, Kronmal RA, et al. Thickening of the carotid wall. A marker for atherosclerosis in the elderly? Cardiovascular Health Study Collaborative Research Group. Stroke. 1996 ; 27: 224-231.
20. Meredith IT, Currie KE, Anderson TJ, Roddy MA, Ganz P., Creager MA Postischemic vasodilation in human forearm is dependent on endothelium-derived nitric oxide. Am J Physiol. 1996 ; 270: H1435 - H1440.
21. Vita JA, Keaney JF Jr, Larson MG, et al. Brachial artery vasodilator function and systemic inflammation in the Framingham Offspring Study. Circulation. 2004 ; 110: 3604-3609.
22. Celermajer DS, Sorensen KE, Georgakopoulos D., et al. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation. 1993 ; 88: 2149-2155.
23. Ducharme A., Dupuis J., McNicoll S., Harel F., Tardif JC Comparison of nitroglycerin lingual spray and sublingual tablet on time of onset and duration of brachial artery vasodilation in normal subjects. Am J Cardiol. 1999 ; 84: 952-9544, A8.
24. Adams MR, Robinson J., McCredie R., et al. Smooth muscle dysfunction occurs independently of impaired endothelium-dependent dilation in adults at risk of atherosclerosis. J Am Coll Cardiol. 1998 ; 32: 123-127.
25. Gokce N., Holbrook M., Duffy SJ, et al. Effects of race and hypertension on flow-mediated and nitroglycerin-mediated dilation of the brachial artery. Hypertension. 2001 ; 38: 1349-1354.
26. Kato M., Roberts-Thomson P., Phillips BG, et al. Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea. Circulation. 2000 ; 102: 2607-2610.
27. Soler N., Ewig S., Torres A., Filella X., Gonzalez J., Zaubet A. Airway inflammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary disease. Eur Respir J. 1999 ; 14: 1015-1022.
28. Jimenez Ruiz CA, Rajas O., Ruiz A., et al. Bronchoalveolar lavage in smokers: quantification of alveolar macrophages and neutrophils as markers of bronchial obstruction. In Vivo. 1998 ; 12: 427-430.
29. Kathiresan S., Larson MG, Vasan RS, et al. Common genetic variation at the endothelial nitric oxide synthase locus and relations to brachial artery vasodilator function in the community. Circulation. 2005 ; 112: 1419-1427.
30. Sin DD, Lacy P., York E., Man SF Effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2004 ; 170: 760-765.
31. Verma S., Li SH, Badiwala MV, et al. Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein. Circulation. 2002 ; 105: 1890-1896.
32. Kiechl S., Werner P., Egger G., et al. Active and passive smoking, chronic infections, and the risk of carotid atherosclerosis: prospective results from the Bruneck Study. Stroke. 2002 ; 33: 2170-2176.
33. Yan RT, Anderson TJ, Charbonneau F., Title L., Verma S., Lonn E. Relationship between carotid artery intimamedia thickness and brachial artery flow-mediated dilation in middle-aged healthy men. J Am Coll Cardiol. 2005 ; 45: 1980-1986.
34. Kalinowski L., Dobrucki LW, Szczepanska-Konkel M., et al. Third-generation beta-blockers stimulate nitric oxide release from endothelial cells through ATP efflux: a novel mechanism for antihypertensive action. Circulation. 2003 ; 107: 2747-2752.
35. Lekakis JP, Protogerou A., Papamichael C., et al. Effect of nebivolol and atenolol on brachial artery flow-mediated vasodilation in patients with coronary artery disease. Cardiovasc Drugs Ther. 2005 ; 19: 277-281.
36. MacCallum PK Markers of hemostasis and systemic inflammation in heart disease and atherosclerosis in smokers. Proc Am Thorac Soc. 2005 ; 2: 34-43.
37. Reuben DB, Judd-Hamilton L., Harris TB, Seeman TE The associations between physical activity and inflammatory markers in high-functioning older persons: MacArthur Studies of Successful Aging. J Am Geriatr Soc. 2003 ; 51: 1125-1130.
38. Rabinovich RA, Figueras M., Ardite E., et al. Increased tumour necrosis factor-alpha plasma levels during moderate-intensity exercise in COPD patients. Eur Respir J. 2003 ; 21: 789-794.